Combining our time-tested abilities in developed and emerging international markets

The Causeway International Opportunities strategy is a blend of Causeway’s best skills, combining our international value (bottom-up, fundamental, developed international markets, excluding the US) and emerging markets (quantitatively managed with a targeted tracking error of 5%) equity strategies. Tracking error is a measurement of dispersion from a benchmark index. Our quantitative research team developed a proprietary multi-factor model that measures the relative attractiveness of emerging markets, and guides the portfolio managers in tactically allocating between the developed and emerging portfolio segments.

Benchmark
MSCI ACWI ex US
Inception
June 30, 2007
Download Profile Sheet Download Flash Report Download Quarterly Review Risk Disclosures
Contact Us

Strategy overview

The portfolio managers discuss our International Opportunities strategy.

Portfolio managers

Fundamental Portfolio Manager
Fundamental Portfolio Manager
Quantitative Portfolio Manager
President
Head of Fundamental Research
Fundamental Portfolio Manager
Head of Quantitative Research
Quantitative Portfolio Manager
Chief Executive Officer
Fundamental Portfolio Manager
Quantitative Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager
Quantitative Portfolio Manager
Fundamental Portfolio Manager
Fundamental Portfolio Manager

Performance

Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 6.8%28.6%20.0%27.6%16.0%9.8%6.1%
Strategy (net) 6.7%28.1%19.5%27.0%15.5%9.3%5.7%
MSCI ACWI ex US 7.0%26.6%17.1%21.3%10.8%8.8%4.4%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 6.8%28.6%20.0%27.6%16.0%9.8%6.1%
Strategy (net) 6.7%28.1%19.5%27.0%15.5%9.3%5.7%
MSCI ACWI ex US 7.0%26.6%17.1%21.3%10.8%8.8%4.4%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 6.8%28.6%20.0%27.6%16.0%9.8%6.1%
Strategy (net) 6.7%28.1%19.5%27.0%15.5%9.3%5.7%
MSCI ACWI ex US 7.0%26.6%17.1%21.3%10.8%8.8%4.4%
Table Header QTD YTD 1 year3 years5 years10 years Since inception
Strategy (gross) 6.8%28.6%20.0%27.6%16.0%9.8%6.1%
Strategy (net) 6.7%28.1%19.5%27.0%15.5%9.3%5.7%
MSCI ACWI ex US 7.0%26.6%17.1%21.3%10.8%8.8%4.4%
Fund 20242023202220212020201920182017201620152014201320122011
Strategy (gross) 10.0%24.8%-11.1%8.0%6.5%23.4%-17.9%31.8%1.9%-4.0%-3.9%22.2%26.0%-11.7%
Strategy (net) 9.5%24.3%-11.4%7.6%6.1%22.9%-18.2%31.3%1.5%-4.4%-4.2%21.7%25.5%-12.0%
MSCI ACWI ex US 6.1%16.2%-15.6%8.3%11.1%22.1%-13.8%27.8%5.0%-5.3%-3.4%15.8%17.4%-13.3%
Table Header
Strategy (gross)
Strategy (net)
MSCI ACWI ex US
20242023202220212020201920182017201620152014201320122011
10.0%24.8%-11.1%8.0%6.5%23.4%-17.9%31.8%1.9%-4.0%-3.9%22.2%26.0%-11.7%
9.5%24.3%-11.4%7.6%6.1%22.9%-18.2%31.3%1.5%-4.4%-4.2%21.7%25.5%-12.0%
6.1%16.2%-15.6%8.3%11.1%22.1%-13.8%27.8%5.0%-5.3%-3.4%15.8%17.4%-13.3%

Portfolio (as of September 30, 2025)

Benchmark: MSCI ACWI ex US
Asset Allocation
Table Header Strategy
Stocks 98.9%
Cash 1.1%
Strategy Characteristics
Table Header Strategy Benchmark
No. of holdings 236 1965
Weighted avg. market cap (US $MM) $106,283 $117,835
FY2 price/earnings 11.9 14.3
Price/book value 1.7 2.1
Dividend yield (%) 2.7 2.7
TOP 10 HOLDINGS
Security Country Percent
Kering SA France 4.3%
Alstom SA France 2.8%
Reckitt Benckiser Group Plc United Kingdom 2.5%
Rolls-Royce Holdings Plc United Kingdom 2.4%
Barclays PLC United Kingdom 2.3%
AstraZeneca PLC United Kingdom 2.2%
Renesas Electronics Corp. Japan 2.1%
Roche Holding AG Switzerland 1.8%
Akzo Nobel Netherlands 1.7%
FANUC Corp. Japan 1.6%

A “weighted average” measures a characteristic by the market capitalization of each stock. Price/book ratio is the weighted average of the price/book ratios of all the stocks in a portfolio. The P/B ratio of a company is calculated by dividing the market price of its stock by the company’s per-share book value. The price/earnings ratio is the weighted average of the price/earnings ratios of the stocks in a portfolio. The FY2 P/E ratio is a forward P/E ratio using a next-twenty-four months EPS estimate in the denominator.

Holdings are subject to change.

SECTOR WEIGHTS
Sector Strategy Benchmark
Financials 18.1% 24.9%
Information Technology 16.0% 13.9%
Industrials 15.4% 14.7%
Consumer Discretionary 11.4% 10.6%
Health Care 11.0% 7.7%
Consumer Staples 7.6% 6.2%
Communication Services 5.9% 6.3%
Materials 5.6% 6.7%
Utilities 2.8% 3.0%
Equity Funds 1.8% 0.0%
Real Estate 1.5% 1.6%
Energy 0.8% 4.5%
TOP 10 COUNTRIES
Country Strategy Benchmark
United Kingdom 22.2% 9.0%
France 14.2% 6.7%
China 11.1% 9.5%
Japan 8.0% 13.7%
Taiwan 6.3% 5.9%
Germany 6.3% 6.1%
Netherlands 5.5% 3.0%
South Korea 4.7% 3.3%
India 3.8% 4.6%
Canada 2.2% 8.3%
Regional Allocation
  • Euro 29.9%
  • Emerging Asia 26.5%
  • Europe - Other 26.2%
  • Pacific 9.0%
  • North America 2.5%
  • Emerging Europe, Middle East, Africa 2.2%
  • Emerging Latin America 1.7%
  • Multi-National Emerging 0.0%

Commentary (As of September 30, 2025)

Highlights

  • Global equities continued their advance in September with all regions delivering positive returns during the month.
  • US tariff negotiations with China are ongoing and the situation is complex – the average effective tariff rate far exceeds the reciprocal tariff rate due to various other tariffs on specific goods. We are overweight Chinese stocks in the Portfolio due in part to compelling valuation and growth characteristics.
  • In the developed markets portion of the portfolio, we are investing in companies with, in our view, durable pricing power, strong brands, and resilient product pipelines, and we view periods of temporary underperformance as opportunities to build positions at compelling valuations. We aim to hold management teams accountable for accelerating operational restructuring and improving shareholder returns. We remain confident that active management and disciplined stock selection should continue to uncover attractive opportunities across global markets.

Portfolio Attribution

The Portfolio underperformed the Index during the month, due primarily to stock selection. Portfolio holdings in the semiconductors & semi equipment, food beverage & tobacco, and consumer discretionary distribution & retail industry groups detracted from relative performance. Holdings in the consumer durables & apparel, financial services, and household & personal products industry groups offset some of the underperformance compared to the Index. The largest detractor was alcoholic beverage distributor, Diageo Plc (United Kingdom). Additional notable detractors included cruise ship operator, Carnival Corp. (United States), and pharmaceutical company, AstraZeneca PLC (United Kingdom). The top contributor to return was multinational luxury conglomerate, Kering SA (France). Other notable contributors included integrated circuit manufacturer, Taiwan Semiconductor Manufacturing Co., Ltd. (Taiwan), and internet commerce company, Alibaba Group Holding Ltd. - ADR (China).

Investment Outlook

In the absence of more policy shocks, we believe the headwinds to US job growth from immigration reform and tariff uncertainty may ease next year. An upturn in employment may in turn limit US rate cuts. We believe concentration risk in US equities underscores the importance of diversification, with 40% of the S&P 500 index in its top ten stocks. Continued enthusiasm around AI may underpin market leadership through year-end to growth in the US and emerging markets, with value potentially leading in Europe and Japan. Although the valuation gap between US and non-US markets has narrowed, it remains wide by historical standards, even excluding the richly priced “Mag 7.” In the developed markets portion of the portfolio, we are investing in companies with, in our view, durable pricing power, strong brands, and resilient product pipelines, and we view periods of temporary underperformance as opportunities to build positions at compelling valuations. We aim to hold management teams accountable for accelerating operational restructuring and improving shareholder returns. We remain confident that active management and disciplined stock selection should continue to uncover attractive opportunities across global markets.

In emerging markets, the tariff outlook for EM exports has generally improved, which has also bolstered EM assets. Reciprocal tariff rates in South Korea and Taiwan have been reduced and many goods, notably semiconductors, are excluded from the reciprocal tariffs currently. US tariff negotiations with China are ongoing and the situation is complex – the average effective tariff rate far exceeds the reciprocal tariff rate due to various other tariffs on specific goods. We are overweight Chinese stocks in the Portfolio due in part to compelling valuation and growth characteristics. In South Korea, corporate governance continues to improve. The Korean parliament passed an amendment to the Korean Commercial Act, which expands companies’ boards of directors’ fiduciary duties to also consider the interests of minority shareholders. We are overweight South Korean stocks in the Portfolio due in part to favorable valuation, growth, price momentum, and top-down characteristics.

The market commentary expresses the portfolio managers’ views as of the date of this report and should not be relied on as research or investment advice regarding any stock. These views and the portfolio holdings and characteristics are subject to change. There is no guarantee that any forecasts made will come to pass. The securities identified and described above do not represent all of the securities purchased, sold or recommended for client accounts. The reader should not assume that an investment in the securities identified was or will be profitable. Past performance does not guarantee future results. For a description of our performance attribution methodology, or to obtain a list showing every holding's contribution to the overall account's performance during the quarter, please contact our product manager, Kevin Moutes, at 310-231-6116 or [email protected].